Skip to main contentSkip to navigation
Sirius Investors

SWGHF Stock: Sawai Group Holdings Co., Ltd. Stock Price, Analysis & Insights

Get live SWGHF stock price $11.52, comprehensive Sawai Group Holdings Co., Ltd. stock analysis, charts, news, and expert forecast. Real-time SWGHF stock data and investment insights.

11.52
0.00%Today
SWGHFSawai Group Holdings Co., Ltd. • Other OTC • Healthcare
Market Cap
1.33B
Volume
120
52W High
11.52
52W Low
11.52

Loading chart data...

Sawai Group Holdings Co., Ltd. (SWGHF) Overview

Sawai Group Holdings Co., Ltd. (SWGHF) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, SWGHF trades at $11.52 with a market capitalization of 1.33B . Over the past 52 weeks, SWGHF has traded between $11.52 and $11.52 , with the current price positioned at approximately NaN% of t...

Key Takeaways

  • Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
  • Market cap: 1.33B
  • Current price: $11.52
  • 52-week range: $11.52 - $11.52
  • P/E ratio: 15.57

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Sawai Group Holdings Co., Ltd., along with its subsidiaries, specializes in the research, development, manufacture, and commercialization of generic pharmaceuticals, primarily serving markets in Japan and the United States. The company's extensive po...

Company Information

CEO
Mitsuo Sawai
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
3482

Contact Information

Address
5-2-30, Miyahara
Country
JP

Investment Analysis & Business Insights

Healthcare
Drug Manufacturers - Specialty & Generic

Investment Highlights

Strong presence in the Healthcare sector with established market position

Valuation metrics suggest potential value opportunity (P/E: 15.6)

Lower volatility stock (Beta: 0.03) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Sawai Group Holdings Co., Ltd. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Sawai Group Holdings Co., Ltd.
  • Investors should consider how Sawai Group Holdings Co., Ltd. fits within their overall portfolio allocation

Market Cap

1.33B

P/E Ratio (TTM)

15.57

Beta

0.03

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.